Frontiers in Aging Neuroscience (Dec 2023)
A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer’s disease mouse models through attenuating mitochondrial function
- Yamei Wang,
- Yamei Wang,
- Jianhao Wang,
- Jianhao Wang,
- Hongyu Chen,
- Hongyu Chen,
- Xiang Li,
- Xiang Li,
- Ruifeng Xu,
- Feng Gao,
- Feng Gao,
- Hang Yu,
- Hang Yu,
- Fang Li,
- Fang Li,
- Dongdong Qin,
- Dongdong Qin,
- Jiabei Wang,
- Jiabei Wang,
- Yuke Shi,
- Yuke Shi,
- Yiyi Li,
- Yiyi Li,
- Songyan Liu,
- Songyan Liu,
- Xi Zhang,
- Xi Zhang,
- Shuai Ding,
- Shuai Ding,
- Yiqian Hu,
- Yiqian Hu,
- Liqin Huang,
- Liqin Huang,
- Xin-Ya Gao,
- Xin-Ya Gao,
- Zuneng Lu,
- Zuneng Lu,
- Jin Luo,
- Zhi-Hao Wang,
- Zhi-Hao Wang
Affiliations
- Yamei Wang
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Yamei Wang
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Jianhao Wang
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Jianhao Wang
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Hongyu Chen
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Hongyu Chen
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Xiang Li
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Xiang Li
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Ruifeng Xu
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Feng Gao
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Feng Gao
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Hang Yu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Hang Yu
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Fang Li
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Fang Li
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Dongdong Qin
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Dongdong Qin
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Jiabei Wang
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Jiabei Wang
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Yuke Shi
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Yuke Shi
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Yiyi Li
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Yiyi Li
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Songyan Liu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Songyan Liu
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Xi Zhang
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Xi Zhang
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Shuai Ding
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Shuai Ding
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Yiqian Hu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Yiqian Hu
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Liqin Huang
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Liqin Huang
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Xin-Ya Gao
- Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, China
- Xin-Ya Gao
- Laboratory of Neurology, Henan Provincial People’s Hospital, Zhengzhou, China
- Zuneng Lu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Zuneng Lu
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- Jin Luo
- Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan, China
- Zhi-Hao Wang
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China
- Zhi-Hao Wang
- Center for Neurodegenerative Disease Research, Renmin Hospital of Wuhan University, Wuhan, China
- DOI
- https://doi.org/10.3389/fnagi.2023.1293164
- Journal volume & issue
-
Vol. 15
Abstract
IntroductionAlzheimer’s disease (AD) is the most prevalent neurodegenerative disease characterized by extracellular senile plaques including amyloid-β peptides and intracellular neurofibrillary tangles consisting of abnormal Tau. Depression is one of the most common neuropsychiatric symptoms in AD, and clinical evidence demonstrates that depressive symptoms accelerate the cognitive deficit of AD patients. However, the underlying molecular mechanisms of depressive symptoms present in the process of AD remain unclear.MethodsDepressive-like behaviors and cognitive decline in hTau mice were induced by chronic restraint stress (CRS). Computational prediction and molecular experiments supported that an asparagine endopeptidase (AEP)-derived Tau fragment, Tau N368 interacts with peroxisome proliferator-activated receptor delta (PPAR-δ). Further behavioral studies investigated the role of Tau N368-PPAR-δ interaction in depressive-like behaviors and cognitive declines of AD models exposed to CRS.ResultsWe found that mitochondrial dysfunction was positively associated with depressive-like behaviors and cognitive deficits in hTau mice. Chronic stress increased Tau N368 and promoted the interaction of Tau N368 with PPAR-δ, repressing PPAR-δ–mediated transactivation in the hippocampus of mice. Then we predicted and identified the binding sites of PPAR-δ. Finally, inhibition of AEP, clearance of Tau N368 and pharmacological activation of PPAR-δ effectively alleviated CRS-induced depressive-like behaviors and cognitive decline in mice.ConclusionThese results demonstrate that Tau N368 in the hippocampus impairs mitochondrial function by suppressing PPAR-δ, facilitating the occurrence of depressive-like behaviors and cognitive decline. Therefore, our findings may provide new mechanistic insight in the pathophysiology of depression-like phenotype in mouse models of Alzheimer’s disease.
Keywords